Adductor Canal Block With or Without Biceps Femoris Short Head Block in Total Knee Arthroplasty
Effect of Adding a Biceps Femoris Short Head Block to an Adductor Canal Block on Postoperative Pain and Functional Outcomes After Total Knee Arthroplasty: A Randomized Controlled Trial
1 other identifier
interventional
132
1 country
1
Brief Summary
Total knee arthroplasty is associated with moderate to severe postoperative pain, which may delay mobilization and recovery. Multimodal analgesia including regional anesthesia techniques is widely used to improve outcomes. The adductor canal block (ACB) provides anteromedial knee analgesia but may not adequately cover the posterolateral region. The biceps femoris short head (BiFeS) block is a novel motor-sparing regional anesthesia technique targeting the posterolateral capsule of the knee. This randomized controlled trial aims to compare the analgesic efficacy and functional outcomes of ACB combined with BiFeS block versus ACB alone in patients undergoing total knee arthroplasty. The primary outcome is posterior knee pain at postoperative 6 hours. Secondary outcomes include pain scores within 48 hours, opioid consumption, early and late functional recovery, and opioid-related adverse effects.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started May 2026
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
April 23, 2026
CompletedFirst Posted
Study publicly available on registry
May 5, 2026
CompletedStudy Start
First participant enrolled
May 15, 2026
ExpectedPrimary Completion
Last participant's last visit for primary outcome
January 15, 2027
Study Completion
Last participant's last visit for all outcomes
February 15, 2027
May 5, 2026
April 1, 2026
8 months
April 23, 2026
April 29, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Posterior Knee Pain Intensity
Posterior knee pain assessed using the Numeric Rating Scale (NRS, 0-10), where 0 indicates no pain and 10 indicates worst imaginable pain.
6 hours postoperatively
Secondary Outcomes (7)
Postoperative Pain Intensity
30 minutes, 1, 6, 12, 24, and 48 hours postoperatively
Total Opioid Consumption
0-48 hours postoperatively
Rescue Analgesic Use
0-48 hours postoperatively
Functional Recovery
24 hours, 48 hours, and 6 weeks postoperatively
Quadriceps Muscle Strength
Preoperatively, 24 hours, 48 hours, and 6 weeks postoperatively
- +2 more secondary outcomes
Study Arms (2)
ACB + BiFeS
EXPERIMENTALParticipants receive spinal anesthesia followed by an ultrasound-guided adductor canal block and a biceps femoris short head block using local anesthetic for postoperative analgesia.
ACB + sham BiFeS
ACTIVE COMPARATORParticipants receive spinal anesthesia followed by an ultrasound-guided adductor canal block and a sham biceps femoris short head block using normal saline.
Interventions
Ultrasound-guided adductor canal block performed with injection of local anesthetic into the adductor canal to block the saphenous nerve and provide postoperative analgesia following total knee arthroplasty.
Ultrasound-guided biceps femoris short head block performed with injection of local anesthetic between the biceps femoris short head and femur to target the posterolateral innervation of the knee for postoperative analgesia.
Sham ultrasound-guided biceps femoris short head block performed with injection of normal saline at the same anatomical location to maintain blinding without providing active analgesia.
Eligibility Criteria
You may qualify if:
- ASA I-III
- Adult patients undergoing unilateral primary TKA
- Planned spinal anesthesia
- Written informed consent
You may not qualify if:
- Coagulopathy
- Drug allergy
- BMI \> 35
- Renal/hepatic failure
- Chronic pain or opioid use
- Depression or psychiatric disorder
- Revision or bilateral TKA
- Neurological deficits
- Preoperative ROM \< 90°
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Cukurova University
Adana, Saricam, 01330, Turkey (Türkiye)
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- QUADRUPLE
- Who Masked
- PARTICIPANT, CARE PROVIDER, INVESTIGATOR, OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Associate Professor of Anesthesiology
Study Record Dates
First Submitted
April 23, 2026
First Posted
May 5, 2026
Study Start (Estimated)
May 15, 2026
Primary Completion (Estimated)
January 15, 2027
Study Completion (Estimated)
February 15, 2027
Last Updated
May 5, 2026
Record last verified: 2026-04
Data Sharing
- IPD Sharing
- Will not share
Individual participant data will not be shared.